AstraZeneca PLC (NYSE:AZN)

44.58
Delayed Data
As of Aug 23
 -0.83 / -1.83%
Today’s Change
35.30
Today|||52-Week Range
45.69
+17.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues24.7B22.9B22.7B22.1B
 
 
 
 
 
Cost of Goods Sold3.4B3.3B3.4B3.4B
 
 
 
 
 
Depreciation And Amortization2.7B2.3B2.5B2.8B
 
 
 
 
 
 
Operating ExpensesGross Income18.6B17.4B16.8B15.8B
 
 
 
 
 
General Expenses15.0B13.8B13.3B14.0B
 
 
 
 
 
Other Operating Expenses-113.8M0.000.000.00
 
 
Research And Development5.6B5.6B5.5B5.3B
 
 
 
 
 
Total Operating Expenses21.0B19.4B19.2B20.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.7B3.6B3.5B1.8B
 
 
 
 
 
Extraordinary Credit387.4M996.4M32.3M373.4M
 
 
 
 
 
Extraordinary Charge-2.1B-2.1B-2.3B-1.5B
 
 
 
 
 
Interest Expense On Debt391.4M615.4M671.1M739.7M
 
 
 
 
 
Equity In Earnings-16.0M-32.9M-55.6M-112.8M
 
 
 
 
 
Other Expenses1.4B1.7B1.6B2.0B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.1B3.6B2.3B2.1B
 
 
 
 
 
Income Taxes-242.6M-145.6M-647.9M-56.9M
 
 
 
 
 
Minority Interest-998.4K-92.8M-134.4M-104.8M
 
 
 
 
 
Net Income2.8B3.5B3.0B2.2B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$1.11$1.38$1.20$0.85
 
 
 
 
 
EPS Diluted$1.11$1.38$1.20$0.85